Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Cartibeads for Chondral Lesions of the Knee
NCT06897111Phase 2Completed
- Sponsor
- Vanarix
- Start
- Jun 2024
- Primary completion
- Feb 2025
- Modality
- Implantable Devices, Implantable Hydrogels, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic cartibeads in cartilage lesion, sponsored by Vanarix. Started Jun 2024; status: completed.
02
Drugs
allogeneic cartibeads
03
Conditions
cartilage lesion
Beyond the preview
Go deeper on NCT06897111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06897111.